Ventricular endocrine and mechanical function following thrombolysis for acute myocardial infarction

International Journal of Cardiology

Volumn 117, Issue 1, 2007, Pages 51-58

  Ramzy, Ihab S ^a   Daly, Caroline A ^b   O'Sullivan, Christine A ^b   Lam, Yat Yin ^b   Kemp, Michael ^b   Hooper, James ^b   Dancy, Mark ^a   Henein, Michael Y ^c  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Myocardial infarction; Natriuretic peptides; Thrombolysis; Ventricular function

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AMPLITUDE MODULATION; ARTICLE; BLOOD CLOT LYSIS; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE FUNCTION; HEART VENTRICLE WALL; HOSPITAL ADMISSION; HUMAN; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SAMPLE SIZE; TREATMENT OUTCOME;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VENTRICULAR FUNCTION;

EID: 33947114779     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.04.052     Document Type: Article

References (23)

1. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
2. Suzuki T., Yamaoki K., Nakajima O., et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels. Jpn Heart J 41 (2000) 205-214
3. Lerman A., Gibbons R.J., Rodeheffer R.J., et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 341 (1993) 1105-1109
4. Bettencourt P., Frioes F., Azevedo A., et al. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol 93 (2004) 45-48
5. Darbar D., Davidson N.C., Gillespie N., et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 78 (1996) 284-287
6. De Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
7. Omland T., de Lemos J.A., Morrow D.A., et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 89 (2002) 463-465
8. Omland T., Aakvaag A., Bonarjee V.V.S., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
9. Lang C.C., Choy A.M.J., and Struthers A.D. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci 83 (1992) 519-527
10. Jougasaki M., Yasue H., Mukoyama M., Nakao K., and Takahashi K. Appearance of atrial natriuretic peptide in the ventricles in patients with myocardial infarction. Am Heart J 119 (1990) 92-96
11. Morita E., Yasue H., Yoshimura M., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 82-91
12. Duncan A.M., O'Sullivan C.A., Carr-White G.S., Gibson D.G., and Henein M.Y. Long axis electromechanics during dobutamine stress in patients with coronary artery disease and left ventricular dysfunction. Heart 86 (2001) 397-404
13. Alam M. The atrioventricular plane displacement as a means of evaluating left ventricular systolic function in acute myocardial infarction. Clin Cardiol 14 (1991) 588-594
14. Alam M., Hoglund C., and Thorstrand C. Longitudinal systolic shortening of the left ventricle: an echocardiographic study in subjects with and without preserved global function. Clin Physiol 12 (1992) 443-452
15. Greenbaum R.A., Ho S.Y., Gibson D.G., Becker A.E., and Anderson R.H. Left ventricular fibre architecture in man. Br Heart J 45 (1981) 248-263
16. Streeter Jr. D.D., Spotnitz H.M., Patel D.P., Ross Jr. J., and Sonnenblick E.H. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res 24 (1969) 339-347
17. Alam M., and Hoglund C. Serial echocardiographic studies following thrombolytic treatment in myocardial infarction with special reference to the atrioventricular valve plane displacement. Clin Cardiol 15 (1992) 30-36
18. Hoglund C., Alam M., and Thorstrand C. Effects of acute myocardial infarction on the displacement of the atrioventricular plane: an echocardiographic study. J Intern Med 226 (1989) 251-256
19. Sumida H., Yasue H., Yoshimura M., et al. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol 25 (1995) 1105-1110
20. Nagaya N., Nishikimi T., Goto Y., et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 135 (1998) 21-28
21. Crilley J.G., and Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart 86 (2001) 638-642
22. O'Sullivan C.A., Ramzy I.S., Li W., et al. The effect of the localization of Q wave myocardial infarction on ventricular electromechanics. Int J Cardiol 84 (2002) 241-247
23. Matsubara H., Nishikawa M., Umeda Y., et al. The role of atrial pressure in secreting atrial natriuretic polypeptides. Am Heart J 113 (1987) 1457-1463